• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® ACUSEAL VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® ACUSEAL VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER Back to Search Results
Device Problem Material Deformation (2976)
Patient Problem Occlusion (1984)
Event Date 01/02/2021
Event Type  Injury  
Manufacturer Narrative
Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Event Description
The following information was reported to gore: in an article titled "endovascular treatment of arteriovenous graft dysfunction as a result of graft delamination and fracture" it states the following: background: graft thrombosis due to fabric delamination is a rare cause of delayed failure of arteriovenous grafts.Graft delamination is primarily an imaging diagnosis and is confirmed with the help of ultrasound which shows the separation of graft fabric layers.Only two such cases have been described in the literature so far.Case presentation: we present a case of upper extremity arteriovenous graft thrombosis in a (b)(6) year old covid-19 positive patient with end-stage renal disease.The diagnosis was established on ultrasonography which revealed separation of the graft fabric layers with thrombosis within the "false" and "true" lumen of the graft.The patient was managed with angioplasty and embolectomy of the clot material followed by stent-graft placement across the delaminated portion of the graft.Post-procedural angiography confirmed brisk flow across the graft and patient could successfully have subsequent hemodialysis sessions.Conclusions: identification of graft delamination as a cause of graft failure is important as its management differs from other conventional causes since it requires stent-grafts to cover the area of delamination to re-establish flow and salvage the av graft.The recognition of this phenomenon is essential to provide quality care and successful reuse of the av graft.
 
Manufacturer Narrative
Literature citation: chaurasia, a., et al.2021.Endovascular treatment of arteriovenous graft dysfunction as a result of graft delamination and fracture.Cvir endovascular 4:1-4.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® ACUSEAL VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
heidi inskeep
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key11155992
MDR Text Key226316914
Report Number2017233-2021-01594
Device Sequence Number1
Product Code DSY
Combination Product (y/n)Y
Reporter Country CodeIN
PMA/PMN Number
K130215
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 11/09/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/12/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/09/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Other;
Patient Age79 YR
Patient SexFemale
-
-